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Objective: To investigate in a large sample of consecutive patients with neurofibromatosis type 1 (NF1) the
possibility of including the presence of choroidal abnormalities detected by near-infrared reflectance (NIR) as a
new diagnostic criterion for NF1.
Design: Cross-sectional evaluation of a diagnostic test.
Participants and Controls: Ninety-five consecutive adult and pediatric patients (190 eyes) with NF1,
diagnosed based on the National Institutes of Health (NIH) criteria. Controls included 100 healthy age- and
gender-matched control subjects.
Methods: Confocal scanning laser ophthalmoscopy was performed for each subject, investigating the
presence and the number of choroidal abnormalities.
Main Outcome Measures: Sensitivity, specificity, and diagnostic accuracy for the different cutoff values of
the criterion choroidal nodules detected by NIR compared with the NIH criteria.
Results: Choroidal nodules detected by NIR imaging were present in 79 (82%) of 95 of the NF1 patients,
including 15 (71%) of the 21 NF1 pediatric patients. Similar abnormalities were present in 7 (7%) of 100 healthy
subjects, including 2 (8%) of the 25 healthy pediatric subjects. The highest accuracy was obtained at the cutoff
value of 1.5 choroidal nodules detected by NIR imagery. Sensitivity and specificity of the examination at the optimal
cutoff point were 83% and 96%, respectively. Diagnostic accuracy was 90% in the overall population and 83% in the
pediatric population. Both of these values were in line with the most common NIH diagnostic criteria.
Conclusions: Choroidal abnormalities appearing as bright patchy nodules detected by NIR imaging fre-
quently occurred in NF1 patients. The present study shows that NIR examination to detect choroidal involvement
should be considered as a new diagnostic criterion for NF1.
Financial Disclosure(s): The author(s) have no proprietary or commercial interest in any materials discussed
in this article. Ophthalmology 2012;119:369–375 © 2012 by the American Academy of Ophthalmology.
r
a
e
p
s
c
s
c
N
P
A
g
a
p
B
P
(Neurofibromatosis type 1 (NF1) is an autosomal dominant
disorder with an estimated incidence of 1 in every 3000
newborns.1 A minimum of 2 of the following criteria are
required for the diagnosis: 6 or more café au lait spots,
axillary or inguinal freckling, 2 or more cutaneous neuro-
fibromas, 1 plexiform neurofibroma, distinctive osseous le-
sions (e.g., pseudarthrosis, sphenoid wing hypoplasia), optic
glioma, 2 or more iris Lisch nodules, and a first-degree
relative with NF1.2
Choroidal neurofibromatosis, as described in postmortem
examinations,3–8 is characterized by ovoid bodies consist-
ing of proliferating neoplastic Schwann cells that are ar-
ranged in concentric rings around axons. There are only a
few reports of choroidal abnormalities in clinical studies.
Recently in 2 small series, confocal near-infrared reflec-
tance (NIR) imaging provided superior visibility of NF1-
related pathologic features in the choroid.9,10 Choroidal
abnormalities, undetectable with conventional ophthalmo-
scopic examination or in fluorescein angiograms, appeared
as bright, patchy nodules. Indocyanine green angiography,
at a wavelength similar to that of NIR, also is helpful in H
© 2012 by the American Academy of Ophthalmology
Published by Elsevier Inc.ecording fundus alterations associated with NF1, but it is
n invasive diagnostic tool.11 The advantage of NIR imag-
ry for recording pathologic features underneath the retinal
igment epithelium may be the result of the good transmis-
ion of long-wavelength light through melanin and lipofus-
in.12 The purpose of this study was to investigate, in a large
ample of consecutive NF1 patients, the possibility of in-
luding the presence of choroidal abnormalities detected by
IR as a potentially new diagnostic criterion for NF1.
atients and Methods
ll patients and subjects (or their parents if they were children)
ave their informed consent, and the study was conducted in
ccordance with the tenets of the Declaration of Helsinki. The
rotocol of this study was approved by the Institutional Review
oard of Fondazione IRCCS Cà Granda Ospedale Maggiore
oliclinico.
Between September 2008 and October 2009, 95 white patients
190 eyes) with NF1 based on the stringent National Institutes of
ealth (NIH) diagnostic criteria were examined.2 Also, 100 age-,
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Ophthalmology Volume 119, Number 2, February 2012gender-, and race-matched healthy control subjects were exam-
ined. Patients with NF1 were referred to the Eye Clinic of Fonda-
zione IRCCS Cà Granda Ospedale Maggiore Policlinico of Milan
from the Medical Genetic Unit and the Pediatric Department.
Patients for whom the fundus could not be examined because of
media opacity were excluded. Each subject underwent a best-
corrected visual acuity evaluation, general ophthalmologic exam-
ination, including assessment for iris hamartomas (Lisch nodules),
and mydriatic indirect fundus biomicroscopy with a 90-diopter (D)
lens.
Near-infrared reflectance at 815 nm, autofluorescence (AF) at
488-nm excitation and a barrier filter of 500 nm, and red-free (RF)
488-nm images of the posterior pole and mid-periphery of the
retina were recorded routinely with a confocal scanning laser
ophthalmoscope (cSLO; HRAII or Spectralis HRAOCT, Heidel-
berg Engineering, Heidelberg, Germany).13 The same operator
(GB) used different camera objectives to provide 30° and 50° or
more angle field-of-views. With confocal image acquisition, light
from a conjugate plane of interest was detected by the image
sensor. This permitted suppression of light from planes anterior
and posterior to the plane of interest and resulted in high-contrast
fundus images. The image resolution was 768768 pixels. The
Spectralis HRAOCT was used when available in the authors’
clinic after January 2009. The combined cSLO/optical coherence
tomography (OCT) system allowed for simultaneous recording
with precise alignment of OCT images and topographic images,
including NIR, AF, and RF, as previously described in detail.13
The OCT cross-section was placed precisely over the area of
interest to obtain a correlation of the tomographic images to
morphologic changes in the retina and choroid.
Using automated eye tracking and image alignment based on
cSLO images, the software allowed averaging a variable number
Table 1. Demographic and O
Neurofibromatosis Type 1* Contro
Women/men 40/55 48/52
Mean ageSD (yrs) 2816 3018
Range 3–68 4–72
Iris color
Bright 25/95 (26%) 28/100 (2
Dark brown 70/95 (74%) 72/100 (7
Refractive error
Myopia 23/95 (24%) 16/100 (1
Hypermetropia 10/95 (11%) 10/100 (1
Astigmatism 19/95 (20%) 21/100 (2
SD  standard deviation.
*Includes adult and pediatric cases.
Table 2. Frequency of National I
Neurofibromatosis Type 1* Co
Café au lait macules 95/95 (100%) 6/10
Neurofibromas 67/95 (70%) 0/10
Freckling 76/95 (80%) 0/10
Lisch nodules 68/95 (72%) 0/10
Optic glioma 6/95 (6%) 1/10
Distinctive osseus lesion 2/95 (2%) N
First-degree relative affected 46/95 (48%) 1/10
NA  not applicable.
*Includes adult and pediatric cases.
370f single images in real time (ART [Automatic Real Time] Mod-
le; Heidelberg Engineering, Heidelberg, Germany). Choroidal
bnormalities defined as bright, patchy nodules by NIR9,10 were
uantified in the entire detectable fundus oculi by means of a 50°
ens. To study the topographic distribution of the choroidal abnor-
alities, the ocular fundus was divided into 5 areas, as suggested
y Nakakura et al.10 Nodules on the border between the regions
ere assigned to the region containing the greater part of the
esion. All of the images were analyzed in a blind manner by the
ame investigator (D.V.), who looked for choroidal abnormalities
nd any other unusual findings. The same investigator and another
ndependent investigator (C.M.) repeated the analysis to obtain
ata for, respectively, intraobserver and interobserver agreement
valuation.
Data regarding refractive errors, race, and iris color that could
ffect the amount of melanin in the choroid, and consequently the
etection of bright, patchy nodules by NIR, also were noted.
yopia was defined as the spherical equivalent refraction of at
east 0.50 D, hyperopia as the spherical equivalent refraction of
t least 2.0 D, and astigmatism as the cylinder of at least 1.0 D.
tatistical Analysis
requencies of choroidal abnormalities detected by NIR were
ompared between patients and control subjects by the Fisher
xact test. Intraobserver and interobserver agreement over image
cores was calculated using the  statistic, where agreement was
efined according to the guidelines proposed by Landis and
och.14,15
The median test was used to verify the association between the
resence of choroidal nodules detected by NIR and the number of
IH diagnostic criteria. A receiver operating characteristic curve
r Characteristics of Patients
Neurofibromatosis Type 1 (<12 yrs) Controls (<12 yrs)
11/10 12/13
72 82
3–12 4–12
6/21 (29%) 7/25 (28%)
15/21 (71%) 18/25 (72%)
2/21 (9%) 2/25 (8%)
4/21 (19%) 5/25 (20%)
2/21 (11%) 2/25 (8%)
te of Health Diagnostic Criteria
Neurofibromatosis Type 1 (<12 yrs) Controls (<12 yrs)
) 21/21 (100%) 2/25 (8%)
) 3/21 (14%) 0/25 (0%)
) 20/21 (95%) 0/25 (0%)
) 9/21 (43%) 0/25 (0%)
) 1/21 (5%) 0/25 (0%)
0/21 (0%) NA
) 9/21 (43%) 0/25 (0%)cula
ls
8%)
2%)
6%)
0%)
1%)nstitu
ntrols
0 (6%
0 (0%
0 (0%
0 (0%
0 (1%
A
0 (1%
Viola et al  NIR in Neurofibromatosis 1Figure 1. Fundus oculi of a 44-year-old man with neurofibromatosis type 1. A, Both eyes have several bright choroidal nodules that were detected by
near-infrared reflectance. No abnormalities were recognizable by (B) conventional fundus examination, (C) autofluorescence, and (D) red-free imaging.
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Ophthalmology Volume 119, Number 2, February 2012was constructed to show the variability of sensitivity and speci-
ficity for cutoff values for the number of choroidal nodules de-
tected by NIR. The area under the receiver operating characteristic
curve was selected as the global index of diagnostic accuracy. The
optimal cutoff point was selected based on the highest accuracy.
The accuracy of the new criteria were compared with those of
each NIH criterion. The correlations between the number of fundus
areas involved, the age, and the number of positive NIH criteria
were studied by Spearman linear correlation index. A subgroup
analysis was performed on pediatric patients, 12 years old or
Figure 2. Choroidal nodules detected by ocular coherence tomography
reflectance of the left eye shows bright choroidal nodules. The OCT cross-
scan shows that these lesions are located within the choroidal tissue.
Table 3. Frequency
Detection Method
Neurofibromatosis
Type 1*
AF 0/95 (0%)
RF 5/95 (5%)
NIR† 79/95 (82%)
AF  autofluorescence at 488-nm excitation; NIR  n
488-nm excitation.
*Includes adult and pediatric cases.
†P0.001 by Fisher exact test for neurofibromatosis typ
years of age or younger. P0.001 for neurofibromatosis
P0.001 for neurofibromatosis type 1 (12 yrs) detect
Table 4. Patients Grouped b
Choroidal Nodule
Threshold
Neurofibromatosis
Type 1
0 16/95 (18%) 9
1 79/95 (82%)
2 79/95 (82%)
3 76/95 (80%)
4 76/95 (80%)
5 74/95 (78%)
6 71/95 (75%)younger. Data were expressed as meanstandard deviation (range) (
372nd as ratio (percentage) for prevalence data. P values of 0.05 or
ess were considered statistically significant.
esults
here were no significant differences between NF1 and control
ubjects regarding the prevalence of ocular characteristics such as
ris color and refraction (Table 1) or best-corrected visual acuity
). A, In the same subject shown in Figure 1, near-infrared reflectance
nal image was obtained along the green line. B, The corresponding OCT
horoidal Nodules
trols
Neurofibromatosis
Type 1 (<12 yrs)
Controls
(<12 yrs)
(0%) 0/21 (0%) 0/25 (0%)
(4%) 2/21 (9%) 2/25 (8%)
(7%) 15/21 (71%) 2/25 (8%)
frared reflectance at 815 nm; RF  red-free imaging at
. controls and neurofibromatosis type 1 vs. controls 12
1 detection of nodules in NIR vs. RF and NIR vs. AF.
f nodules in NIR vs. RF and NIR vs. AF.
mber of Choroidal Nodules
trols
Neurofibromatosis
Type 1 (<12 yrs)
Controls
(<12 yrs)
(93%) 6/21 (29%) 23/25 (92%)
(7%) 15/21 (71%) 2/25 (8%)
(4%) 15/21 (71%) 2/25 (8%)
(2%) 13/21 (62%) 0/25 (0%)
(2%) 13/21 (62%) 0/25 (0%)
(2%) 12/21 (57%) 0/25 (0%)
(1%) 11/21 (52%) 0/25 (0%)(OCT
sectioof C
Con
0/100
4/100
7/100
ear-in
e 1 vs
typey Nu
Con
3/100
7/100
4/100
2/100
2/100
2/100data not shown). Lisch nodules were detected by slit-lamp exam-
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Viola et al  NIR in Neurofibromatosis 1ination in 68 (72%) of 95 NF1 subjects and in 9 (43%) of 21
pediatric NF1 subjects (Table 2).
Bright, patchy choroidal nodules were detected by NIR (Fig 1)
in 79 (82%) NF1 patients, including 15 pediatric patients (71%).
Conventional fundus examination, including biomicroscopic ex-
amination and fundus colour photography, did not show any re-
markable changes (Fig 1), except in 8 subjects (3 NF1s and 5
controls) with a choroidal nevus in 1 eye. In OCT examinations,
the choroidal abnormalities detected by NIR were observed as
irregular hyperreflective foci located under the retinal pigment
epithelium (Fig 2).
Twenty of 27 patients without Lisch nodules showed choroidal
nodules detected by NIR, and 8 of 16 patients without choroidal
nodules detected by NIR showed Lisch nodules. There was no
significant correlation between the Lisch nodules and the choroidal
nodules (P0.05, Spearman correlation index). Differences in
the frequencies of choroidal nodules detected by NIR between the
entire NF1 subject group and the control group and between the
pediatric NF1 subgroup and controls were significant (P0.001
each, Fisher exact test; Table 3). However, there were no differ-
ences between groups in the frequencies of choroidal nodules
detected by AF or RF. Within the NF1 and NF1 pediatric groups,
NIR detected significantly more nodules than did AF or RF
(P0.001; Table 3). There was no significant difference in the
Figure 3. Receiver operating characteristic curve (ROC) at different
cutoff numbers of choroidal nodules detected by near-infrared reflectance.
Table 5. Sensitivity and Specificity o
Cutoff Value Sensitivity 1–Specifici
0.50 0.832 0.070
1.50 0.832 0.040
3.00 0.800 0.020
4.50 0.779 0.020
5.50 0.747 0.010Boldface values indicate the highest accuracy.roportion of patients with choroidal nodules detected by NIR in
elation to the number of NIH diagnostic criteria (P0.05, chi
quare test).
Using the number of choroidal nodules as threshold values
Table 4), receiver operating characteristic curves were con-
tructed (Fig 3) to determine the sensitivity and specificity of
odules as diagnostic indicators of NF1. The highest accuracy was
btained at the cutoff value of 1.5 choroidal nodules detected by
IR. Sensitivity and specificity of the examination at the optimal
utoff point were 83% and 96%, respectively (Table 5). The area
nder the receiver operating characteristic curve was 0.904 (95%
symptotic confidence interval, 0.856–0.952). For the general
opulation, the accuracy of NIR detection of choroidal nodules,
.90, was somewhat less than that of café au lait macules, the same
s that of freckling, and slightly more than that of neurofibromas
Table 6). For the pediatric population, the accuracy was 0.83,
hich was less than that of freckling and café au lait macules, but
ore than that of Lisch nodules and of having a first-degree
elative affected.
Choroidal abnormalities occurred in all of the regions of the
undus, but were more frequent at the posterior pole (P0.001,
hi-square test and Fisher exact test for the NF1 overall population
nd the NF1 pediatric patients, respectively; Table 7). There was a
tatistically significant correlation between patient age and the
umber of involved fundus areas (Spearman r  0.62; P0.001).
The number of choroidal nodules detected by NIR and the
umber of involved areas showed an almost a perfect intraobserver
  0.948 and   0.970, respectively) and interobserver ( 
.857 and   0.953, respectively) agreement.
iscussion
he frequency of each NF1 clinical manifestation ob-
erved in this study was similar to that reported previ-
roidal Abnormality Cutoff Numbers
Specificity Sensitivity–(1–Specificity)
0.930 0.762
0.960 0.792
0.980 0.780
0.980 0.759
0.990 0.737
Table 6. Diagnostic Criteria Accuracy
Overall
Population
Pediatric Population
(<12 yrs)
afé au lait macules 0.98 0.96
eurofibromas 0.86 0.61
reckling 0.90 0.98
isch nodules 0.86 0.74
ptic glioma 0.54 0.56
istinctive osseus lesion 0.52 0.54
irst degree relative affected 0.74 0.74
horoidal nodules detected by NIR 0.90 0.83
IR  near-infrared reflectance at 815 nm.f Cho
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Ophthalmology Volume 119, Number 2, February 2012ously for adult and children populations.16,17 Notably, the
prevalence of choroidal nodules detected by NIR in the
NF1 overall population was 82%, similar to the NIH
diagnostic criteria. Additionally, in the NF1 pediatric
group, the prevalence of NIR-detected choroidal nodules
was 71%, much higher than the frequency of the NIH
ophthalmic diagnostic criteria of 43% for iris Lisch nod-
ules detected by slit-lamp examination.
With a cutoff value of 1.5 choroidal nodules observed by
NIR imaging, the diagnostic sensitivity was 83% and the
specificity was 96%. Thus, with a diagnostic criterion of 2
or more choroidal abnormalities detected by NIR, there is a
high diagnostic accuracy both in the overall NF1 population
and in the NF1 pediatric population. As described by Ya-
sunari et al9 and Nakakura et al,10 choroidal abnormalities
were easily detectable by NIR light and indocyanine-green
angiograms in 100% of their NF1 patients. However, these
same defects were undetectable using conventional ophthal-
moscopy and fluorescein angiograms. The data presented by
Yasunari et al9 and Nakakura et al10 are not in absolute
consonance with the current results, possibly because of the
small number of subjects included in the 2 series or because
of bias in the enrollment of their patients. For instance,
refractive errors and conditions related to the amount of
melanin in the choroid, such as race and iris color, might
have affected the detection of bright, patchy nodules using
NIR. These were not reported by them.9,10
Regardless of the real prevalence of choroidal involve-
ment, the presence of the bright, patchy regions seen with
NIR imaging seems to be highly specific for NF1 patients.
Seven control subjects with bright patchy nodules detected
by NIR were found. However, 3 of them had only 1 bright
nodule in 1 eye as a result of a choroidal nevus. In the other
4 control subjects, the bright nodules were probably the
result of atrophic areas, vitreoretinal reflex, or optical re-
flectance artifacts. Thus, infrared monochromatic light pen-
etrates the retinal pigment epithelium better than visible
light, showing deeper tissues. Therefore, the bright, patchy
regions noted under infrared light and the absence of such
regions under AF and RF laser monochromatic light by
cSLO or conventional ophthalmoscopy indicate the choroi-
dal localization of the abnormalities. Additionally, high-
resolution OCT, allowing the investigation of the area of
interest on a quasihistologic level, confirmed the choroidal
localization of these abnormalities.
As described by Nakakura et al,10 the present study
found that most choroidal nodules were located at the pos-
Table 7. Topographic Distrib
Neurofibromatosis
Type 1
Area 1 (posterior pole) 151/158 (96%)
Area 2 (supratemporal) 116/158 (73%)
Area 3 (infratemporal) 110/158 (70%)
Area 4 (supranasal) 103/158 (65%)
Area 5 (infranasal) 86/158 (54%)
No. of fundus areas involved
(sum of both eyes)
8.27 (2–10)terior pole, especially in pediatric patients. Furthermore, the
374xtent of ocular fundus involvement was variable and in-
reased with age. The topographic distribution of the ab-
ormalities already has been well discussed.10 The higher
resence at the posterior pole is probably the result of the
reater choroidal thickness and the higher number of mela-
ocytes and neural cells.10 In NF1 patients, these findings
re amplified by the choroidal hamartomatous thickening.18
Recently, the presence of unidentified bright objects
n brain magnetic resonance images has been advocated
s a new diagnostic criterion in young children with 1
eature of NF1. However, this age group needs general
nesthesia for that procedure, thereby reducing the use-
ulness of the investigation.19
In conclusion, NIR imaging allows a noninvasive, quick,
eliable, glare-free examination of the choroid to detect
horoidal nodules. The present study offers the first reliable
ata on the prevalence of choroidal abnormalities in the
F1 population. Further epidemiologic information is es-
ential for testing these findings as an additional new diag-
ostic criterion for NF1. If supported by epidemiologic
tudies, this information will allow the testing of choroidal
bnormalities detected by NIR imaging as an additional
iagnostic criterion for NF1, mainly in infants and in pa-
ients suspected of having the condition.
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